Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression
Brief description of study
This research study invites participants that are taking an antidepressant that has not fully
helped with their depression. MK-1942 is the investigational product under study in this research trial, the participant will be
taking along with their current antidepressant to test its safety and
effectiveness.
If participants agrees to be part of the study they will be asked to complete the following
research procedures: Reviewing and signing the informed consent form, evaluation to see if you qualify
for the study. During the entire course
of the study, participant will be seen by the study doctor for the assessments including safety measures. Vitals, EKG and labs will be done at certain
time points. There will be rating scales
(questions from study staff and outside raters) and some self-assessment
questionnaires.
Participants may have to stop certain medications. Participation will last approximately 8 weeks.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Depression
-
Age: Between 18 Years - 65 Years
-
Gender: Male
Has been on a stable course of
antidepressant therapy for ≥4 weeks
and to remain on their stable
course of background antidepressant therapy through entire study.Had an inadequate response to 2 to 4 different courses of antidepressant therapy (including the current course of antidepressant therapy) of sufficient dose and duration
Updated on
08 Sep 2021.
Study ID: 848507
